Ping Xu Selected Research

Stomach Neoplasms (Stomach Cancer)

1/2024	RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
1/2022	CCDC65, a Gene Knockout that leads to Early Death of Mice, acts as a potentially Novel Tumor Suppressor in Lung Adenocarcinoma.
12/2021	Circular RNA circDNA2 upregulates CCDC6 expression to promote the progression of gastric cancer via miR-149-5p suppression.
10/2020	Epigallocatechin gallate reverses gastric cancer by regulating the long noncoding RNA LINC00511/miR-29b/KDM2A axis.
1/2020	Tumour suppressive long non-coding RNA AFDN-DT inhibits gastric cancer invasion via transcriptional regulation.
1/2018	Low expression of the long non-coding RNA NR_026827 in gastric cancer.
9/2017	Decreased expression of the long non-coding RNA MLLT4 antisense RNA 1 is a potential biomarker and an indicator of a poor prognosis for gastric cancer.
1/2015	Downregulation of long noncoding RNA ZMAT1 transcript variant 2 predicts a poor prognosis in patients with gastric cancer.
3/2008	Novel CADD-based peptidyl vinyl ester derivatives as potential proteasome inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Xu Research Topics

Disease

171	Neoplasms (Cancer) 05/2024 - 01/2002
37	Infections 05/2024 - 06/2003
37	Breast Neoplasms (Breast Cancer) 10/2022 - 09/2007
36	Inflammation (Inflammations) 12/2023 - 03/2004
33	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2004
24	Hypoxia (Hypoxemia) 05/2024 - 08/2002
20	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 03/2008
19	Carcinogenesis 05/2024 - 03/2003
15	Wounds and Injuries (Trauma) 03/2024 - 04/2007
15	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2009
14	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 09/2007
13	Carcinoma (Carcinomatosis) 12/2023 - 04/2004
13	Insulin Resistance 01/2023 - 08/2006
11	Obesity 12/2023 - 07/2006
11	Pancreatitis 03/2023 - 04/2007
11	Non-alcoholic Fatty Liver Disease 01/2023 - 08/2006
10	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 03/2011
10	Hypertension (High Blood Pressure) 01/2024 - 01/2009
10	Fibrosis (Cirrhosis) 01/2023 - 01/2016
10	Adenocarcinoma of Lung 10/2022 - 08/2010
9	Sepsis (Septicemia) 03/2024 - 04/2012
9	Disease Progression 02/2024 - 04/2006
9	Stomach Neoplasms (Stomach Cancer) 01/2024 - 03/2008
9	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2015
9	Liver Diseases (Liver Disease) 12/2023 - 02/2005
9	Cardiovascular Diseases (Cardiovascular Disease) 03/2023 - 02/2005
9	Hyperglycemia 06/2021 - 03/2010
9	Endocarditis 01/2021 - 04/2007
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 04/2017
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2022 - 10/2013
8	Necrosis 02/2022 - 06/2003
8	Body Weight (Weight, Body) 08/2021 - 08/2006
8	Thrombosis (Thrombus) 03/2019 - 03/2011
7	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 04/2011
7	Hemorrhage 01/2024 - 04/2007
7	Virus Diseases (Viral Diseases) 01/2023 - 01/2008
7	Melanoma (Melanoma, Malignant) 07/2021 - 06/2008
7	Pain (Aches) 07/2021 - 09/2005
7	Hyperlipidemias (Hyperlipidemia) 04/2021 - 11/2008
6	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 04/2010
6	Birth Weight (Birth Weights) 03/2024 - 06/2016
6	Parkinson Disease (Parkinson's Disease) 03/2024 - 12/2008
6	Endometrial Neoplasms (Endometrial Cancer) 01/2024 - 04/2011
6	Stroke (Strokes) 01/2024 - 01/2019
6	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 06/2003
6	Pre-Eclampsia (Preeclampsia) 02/2023 - 01/2018
6	Triple Negative Breast Neoplasms 01/2023 - 12/2015
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2017
6	Ischemia 01/2023 - 04/2007
6	Fatty Liver 08/2022 - 05/2006
6	Endometriosis 07/2022 - 11/2015

Drug/Important Bio-Agent (IBA)

96	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2002
36	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2008
26	Messenger RNA (mRNA)IBA 04/2024 - 08/2002
25	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 09/2007
21	Long Noncoding RNAIBA 05/2024 - 01/2015
18	LipidsIBA 12/2023 - 10/2007
18	TeaIBA 11/2023 - 05/2006
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2002
15	MicroRNAs (MicroRNA)IBA 05/2024 - 01/2013
15	CytokinesIBA 12/2023 - 05/2006
13	AutoantibodiesIBA 06/2024 - 09/2007
12	EnzymesIBA 01/2023 - 03/2003
12	AntioxidantsIBA 10/2021 - 01/2008
11	RNA (Ribonucleic Acid)IBA 01/2024 - 06/2003
11	Therapeutic UsesIBA 10/2023 - 03/2004
11	LigandsIBA 10/2023 - 04/2007
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2021 - 04/2007
10	AntigensIBA 04/2024 - 11/2011
10	ProteomeIBA 12/2023 - 01/2013
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2002
10	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2007
10	VaccinesIBA 01/2021 - 11/2011
9	Insulin (Novolin)FDA Link 01/2024 - 08/2006
9	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 02/2005
9	Small Interfering RNA (siRNA)IBA 07/2023 - 07/2010
9	Tyrosine Kinase InhibitorsIBA 01/2021 - 05/2013
8	AntibodiesIBA 06/2024 - 12/2010
8	CollagenIBA 01/2023 - 05/2006
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 09/2008
8	Phosphotransferases (Kinase)IBA 10/2022 - 05/2005
8	PolyphenolsIBA 04/2020 - 05/2006
7	SteroidsIBA 04/2024 - 01/2007
7	Triglycerides (Triacylglycerol)IBA 03/2024 - 10/2013
7	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2023 - 01/2012
7	Oxygen (Dioxygen)IBA 08/2023 - 02/2004
7	Anti-Bacterial Agents (Antibiotics)IBA 02/2023 - 08/2013
7	C-PeptideIBA 10/2021 - 10/2012
7	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 07/2021 - 09/2013
6	LuciferasesIBA 05/2024 - 03/2012
6	Retinaldehyde (Retinal)IBA 04/2023 - 01/2016
6	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 12/2017
6	Circular RNAIBA 01/2023 - 01/2019
6	Peptides (Polypeptides)IBA 01/2023 - 01/2011
6	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 03/2008

Therapy/Procedure

86	Therapeutics 05/2024 - 02/2005
42	Drug Therapy (Chemotherapy) 01/2024 - 04/2007
13	Immunotherapy 02/2024 - 01/2016
8	Transplantation 01/2023 - 02/2005
7	Aftercare (After-Treatment) 07/2023 - 07/2008